Clinical Trial Update: GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of GTI-2040 in combination with capecitabine in metastatic breast cancer completed; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• GTI-2040 (GTI-2040)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-10-31